{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:09:00Z","timestamp":1786975740027,"version":"build-2736575974"},"reference-count":59,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>Digital health applications have been shown to be effective in the management of chronic diseases with simple treatment targets. The potential clinical value of digital health applications in rheumatoid arthritis (RA) has not been well studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To investigate whether assessing patient-reported outcomes using digital health applications could result in disease control for patients with RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN, SETTING, AND PARTICIPANTS<\/jats:title>\n                    <jats:p>This is a multicenter, open-label randomized clinical trial in 22 tertiary hospitals across China. Eligible participants were adult patients with RA. Participants were enrolled from November 1, 2018, to May 28, 2019, with a 12-month follow-up. The statisticians and rheumatologists who assessed disease activity were blinded. Investigators and participants were not blind to group assignment. Analysis was conducted from October 2020 to May 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS<\/jats:title>\n                    <jats:p>Participants were randomly assigned at a 1:1 ratio (block size of 4) to a smart system of disease management group (SSDM) or a conventional care control group. Upon the completion of the 6-month parallel comparison, patients in the conventional care control group were instructed to use the SSDM application for an extension of 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN OUTCOMES AND MEASURES<\/jats:title>\n                    <jats:p>The primary outcome was the rate of patients with disease activity score in 28 joints using the C-reactive protein (DAS28-CRP) of 3.2 or less at month 6.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Of 3374 participants screened, 2204 were randomized, and 2197 patients with RA (mean [SD] age, 50.5 [12.4] years; 1812 [82.5%] female) were enrolled. The study included 1099 participants in the SSDM group and 1098 participants in the control group. At month 6, the rate of patients with DAS28-CRP of 3.2 or less was 71.0% (780 of 1099 patients) in the SSDM group vs 64.5% (708 of 1098 patients) in the control group (difference between groups, 6.6%; 95% CI, 2.7% to 10.4%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.001). At month 12, the rate of patients with DAS28-CRP of 3.2 or less in the control group increased to a level (77.7%) that was comparable with that (78,2%) in the SSDM group (difference between groups, \u22120.2%; 95% CI, \u22123.9% to 3.4%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.90).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS AND RELEVANCE<\/jats:title>\n                    <jats:p>In this randomized clinical trial of RA, the use of a digital health application with patient-reported outcomes was associated with an increase in disease control rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03715595\">NCT03715595<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.8343","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T11:03:41Z","timestamp":1681470221000},"page":"e238343","source":"Crossref","is-referenced-by-count":39,"title":["Management of Rheumatoid Arthritis With a Digital Health Application"],"prefix":"10.1001","volume":"6","author":[{"given":"Chun","family":"Li","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University People\u2019s Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxiang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Xuanwu Hospital Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenchun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Linyi People\u2019s Hospital, Linyi, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengguang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University International Hospital, Zhongguancun Life Science Park, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Mianyang Central Hospital, Mianyang, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, the First People's Hospital of Yunnan Province, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, the First Affiliated Hospital of USTC, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wufang","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Tianjin First Central Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Zhejiang Provincial People\u2019s Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Bethune International Peace Hospital, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, the First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Hebei General Hospital, Shijiazhuang, Hebei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henglian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Tungwah Hospital of Sun Yat-sen University, Dongguan, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwen","family":"Shuai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Xijing Hospital, Xi'an, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[{"name":"School of Statistics and Mathematics, Nanjing Audit university, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengsong","family":"Jia","sequence":"additional","affiliation":[{"name":"Shanghai Gothic Internet Technology Co, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Jia","sequence":"additional","affiliation":[{"name":"Shanghai Gothic Internet Technology Co, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xiao","sequence":"additional","affiliation":[{"name":"Shanghai Gothic Internet Technology Co, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanguo","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University People\u2019s Hospital, Beijing, China"},{"name":"State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China."},{"name":"Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"issue":"6","key":"zoi230266r1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/tmj.2016.0211","article-title":"Outcomes of a mobile phone intervention for heart failure in a minority county hospital population.","volume":"23","author":"Dang","year":"2017","journal-title":"Telemed J E Health"},{"issue":"4","key":"zoi230266r2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nbt.3826","article-title":"The Asthma Mobile Health Study, a large-scale clinical observational study using ResearchKit.","volume":"35","author":"Chan","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"8","key":"zoi230266r3","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/S2589-7500(20)30142-4","article-title":"Applications of digital technology in COVID-19 pandemic planning and response.","volume":"2","author":"Whitelaw","year":"2020","journal-title":"Lancet Digit Health"},{"issue":"7","key":"zoi230266r4","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1016\/S2589-7500(19)30151-7","article-title":"Smartphone and social media-based cardiac rehabilitation and secondary prevention in China (SMART-CR\/SP): a parallel-group, single-blind, randomised controlled trial.","volume":"1","author":"Dorje","year":"2019","journal-title":"Lancet Digit Health"},{"issue":"6","key":"zoi230266r5","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.5429","article-title":"The influence of wireless self-monitoring program on the relationship between patient activation and health behaviors, medication adherence, and blood pressure levels in hypertensive patients: a substudy of a randomized controlled trial.","volume":"18","author":"Kim","year":"2016","journal-title":"J Med Internet Res"},{"issue":"7","key":"zoi230266r6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/art.v73.7","article-title":"2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis.","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"zoi230266r7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"zoi230266r8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"zoi230266r9","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000221","article-title":"When rheumatologists report that they agree with a guideline, does this mean that they practice the guideline in clinical practice: results of the International Recommendation Implementation Study (IRIS).","volume":"2","author":"Gvozdenovic","year":"2016","journal-title":"RMD Open"},{"issue":"3","key":"zoi230266r10","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.33380","article-title":"Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.","volume":"64","author":"Harrold","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"3","key":"zoi230266r11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41584-019-0170-5","article-title":"Treat-to-target in rheumatoid arthritis: are we there yet?","volume":"15","author":"van Vollenhoven","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"zoi230266r12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5152\/eurjrheumatol.","article-title":"Treat-to-target concept implementation for evaluating rheumatoid arthritis patients in daily practice.","volume":"6","author":"Gazitt","year":"2019","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"zoi230266r13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3899\/jrheum.170548","article-title":"Routine use of quantitative disease activity measurements among US rheumatologists: implications for treat-to-target management strategies in rheumatoid arthritis.","volume":"45","author":"Curtis","year":"2018","journal-title":"J Rheumatol"},{"issue":"6","key":"zoi230266r14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","article-title":"Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.","volume":"68","author":"Wells","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"zoi230266r15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/00005650-197903000-00004","article-title":"Active patient orientation and outcomes in hypertensive treatment: application of a socio-organizational perspective.","volume":"17","author":"Schulman","year":"1979","journal-title":"Med Care"},{"issue":"9","key":"zoi230266r16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1176\/ajp.137.9.1081","article-title":"Use of a self-report symptom scale to detect depression in a community sample.","volume":"137","author":"Myers","year":"1980","journal-title":"Am J Psychiatry"},{"issue":"2","key":"zoi230266r17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2190\/Q9KE-38N6-A32H-FFG8","article-title":"Measurement and prediction of recovery after myocardial infarction.","volume":"11","author":"Winefield","year":"1981-1982","journal-title":"Int J Psychiatry Med"},{"issue":"3","key":"zoi230266r18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0304-3959(82)90159-2","article-title":"Stability of self-report measures of improvement in chronic pain: a five-year follow-up.","volume":"12","author":"Toomey","year":"1982","journal-title":"Pain"},{"issue":"3","key":"zoi230266r19","first-page":"275","article-title":"Toward clinical applications of health status measures: sensitivity of scales to clinically important changes.","volume":"19","author":"Deyo","year":"1984","journal-title":"Health Serv Res"},{"issue":"2","key":"zoi230266r20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.rdc.2016.01.010","article-title":"Patient-reported outcomes in rheumatoid arthritis.","volume":"42","author":"van Tuyl","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"zoi230266r21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/ard.2007.084848","article-title":"Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review.","volume":"68","author":"Kalyoncu","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"zoi230266r22","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1136\/annrheumdis-2017-211259","article-title":"Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.","volume":"76","author":"Keystone","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"zoi230266r23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11652","article-title":"Patient-reported outcome measures-challenges and opportunities for China.","volume":"5","author":"Casey","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi230266r24","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/annrheumdis-2013-204798","article-title":"The patient perspective on remission in rheumatoid arthritis: \u2018you\u2019ve got limits, but you\u2019re back to being you again\u2019.","volume":"74","author":"van Tuyl","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"zoi230266r25","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1136\/annrheumdis-2013-203496","article-title":"OMERACT RA Flare Working Group. Validation of OMERACT preliminary rheumatoid arthritis flare domains in the NOR-DMARD study.","volume":"73","author":"Lie","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"zoi230266r26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/rheumatology\/ket416","article-title":"It\u2019s like a juggling act: rheumatoid arthritis patient perspectives on daily life and flare while on current treatment regimes.","volume":"53","author":"Flurey","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"zoi230266r27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/acr.v72.4","article-title":"Assessing rheumatoid arthritis disease activity with patient-reported outcomes measurement information system measures using digital technology.","volume":"72","author":"Yun","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"zoi230266r28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13075-021-02500-3","article-title":"Mobile App-based documentation of patient-reported outcomes - 3-months results from a proof-of-concept study on modern rheumatology patient management.","volume":"23","author":"Richter","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"zoi230266r29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/rheumatology\/keaa202","article-title":"Patient adherence with a smartphone app for patient-reported outcomes in rheumatoid arthritis.","volume":"60","author":"Colls","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"zoi230266r30","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/art.v73.8","article-title":"Outcomes of a mobile app to monitor patient-reported outcomes in rheumatoid arthritis: a randomized controlled trial.","volume":"73","author":"Lee","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"zoi230266r31","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.6956","article-title":"Apps for people with rheumatoid arthritis to monitor their disease activity: a review of apps for best practice and quality.","volume":"5","author":"Grainger","year":"2017","journal-title":"JMIR Mhealth Uhealth"},{"issue":"3","key":"zoi230266r32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/RHU.0000000000000800","article-title":"Mobile apps for individuals with rheumatoid arthritis: a systematic review.","volume":"25","author":"Luo","year":"2019","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"zoi230266r33","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/art.v74.11","article-title":"Smartphone-assisted patient-initiated care versus usual care in patients with rheumatoid arthritis and low disease activity: a randomized controlled trial.","volume":"74","author":"Seppen","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"zoi230266r34","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3390\/s21051576","article-title":"Review of wearable sensor-based health monitoring glove devices for rheumatoid arthritis.","volume":"21","author":"Henderson","year":"2021","journal-title":"Sensors (Basel)"},{"issue":"7","key":"zoi230266r35","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s10067-022-06147-6","article-title":"Daily physical activity measured by a wearable activity monitoring device in patients with rheumatoid arthritis.","volume":"41","author":"Tada","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"10","key":"zoi230266r36","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/acr.v71.10","article-title":"Detection of flares by decrease in physical activity, collected using wearable activity trackers in rheumatoid arthritis or axial spondyloarthritis: an application of machine learning analyses in rheumatology.","volume":"71","author":"Gossec","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"17","key":"zoi230266r37","doi-asserted-by":"publisher","first-page":"4797","DOI":"10.3390\/s20174797","article-title":"Wearable activity trackers in the management of rheumatic diseases: where are we in 2020?","volume":"20","author":"Davergne","year":"2020","journal-title":"Sensors (Basel)"},{"issue":"9","key":"zoi230266r38","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"1","key":"zoi230266r39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/(ISSN)1529-0131","article-title":"Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria.","volume":"39","author":"van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"3","key":"zoi230266r40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/ard.2011.149765","article-title":"American College of Rheumatology\/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.","volume":"70","author":"Felson","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"zoi230266r41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","article-title":"A simplified disease activity index for rheumatoid arthritis for use in clinical practice.","volume":"42","author":"Smolen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"zoi230266r42","doi-asserted-by":"publisher","first-page":"R796","DOI":"10.1186\/ar1740","article-title":"Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.","volume":"7","author":"Aletaha","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"zoi230266r43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/acp.1983.67.issue-6","article-title":"The hospital anxiety and depression scale.","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"zoi230266r44","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"11","key":"zoi230266r45","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1136\/annrheumdis-2012-202281","article-title":"Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation study.","volume":"72","author":"van der Maas","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"zoi230266r46","first-page":"1524","article-title":"Significant improvement of rheumatoid arthritis (RA) outcome with repeated self-assessment applying smart system of disease management (SSDM) mobiles tools: a cohort study of RA patients in china.","volume":"76","author":"Yang","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"zoi230266r47","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/CM9.0000000000000227","article-title":"Clinical deep remission and related factors in a large cohort of patients with rheumatoid arthritis.","volume":"132","author":"Liu","year":"2019","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"zoi230266r48","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10067-014-2828-3","article-title":"Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey.","volume":"34","author":"Wang","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"20","key":"zoi230266r50","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1001\/jama.2021.2433","article-title":"Adjusting for nonadherence or stopping treatments in randomized clinical trials.","volume":"325","author":"Adler","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"zoi230266r51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13063-019-3272-0","article-title":"Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation.","volume":"20","author":"Bingham","year":"2019","journal-title":"Trials"},{"issue":"11","key":"zoi230266r52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/acr2.v4.11","article-title":"Development and testing of an electronic health record-integrated patient-reported outcome application and intervention to improve efficiency of rheumatoid arthritis care.","volume":"4","author":"Solomon","year":"2022","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"zoi230266r53","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001566","article-title":"Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction.","volume":"7","author":"Shaw","year":"2021","journal-title":"RMD Open"},{"issue":"12","key":"zoi230266r54","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/jch.2017.19.issue-12","article-title":"The importance of frequent return visits and hypertension control among US young adults: a multidisciplinary group practice observational study.","volume":"19","author":"King","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"10","key":"zoi230266r55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141217","article-title":"Health behavior change after blood pressure feedback.","volume":"10","author":"Pu","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"zoi230266r56","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.40071","article-title":"mAF-App II Trial investigators. The effects of implementing a mobile health-technology supported pathway on atrial fibrillation-related adverse events among patients with multimorbidity: the mAFA-II randomized clinical trial.","volume":"4","author":"Yao","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi230266r58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41584-020-00527-5","article-title":"How COVID-19 is changing rheumatology clinical practice.","volume":"17","author":"Bonf\u00e1","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"zoi230266r59","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218165","article-title":"Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic.","volume":"80","author":"Santos-Moreno","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"zoi230266r49","doi-asserted-by":"crossref","unstructured":"Rubin? DB. Multiple imputation for nonresponse in surveys. Wiley; 1987. Accessed March 10, 2023. https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9780470316696.fmatter","DOI":"10.1002\/9780470316696"},{"key":"zoi230266r57","doi-asserted-by":"crossref","unstructured":"Jain? D, Norman? K, Werner? Z, Makovoz? B, Baker? T, Huber? S. Using postmarket surveillance to assess safety-related events in a digital rehabilitation app (Kaia App): observational study. JMIR Hum Factors. 2021;8(4):e25453. doi:10.2196\/2545334751664","DOI":"10.2196\/25453"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2803893\/li_2023_oi_230266_1683821626.26728.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T11:00:38Z","timestamp":1684494038000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2803893"}},"subtitle":["A Multicenter, Pragmatic Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.8343","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}